# Quercetin Inflammation Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/quercetin-inflammation-meta-analysis-evidence-review
Category: evidence-review
Summary: Quercetin Inflammation Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mi
Last reviewed: 2026-05-22
Reviewed by: Migaku Evidence Review
# Quercetin Inflammation Meta-analysis: What the Evidence Says

## Quick Answer

Quercetin Inflammation Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Redox Reprogramming of the Diseased Liver by Dietary Flavonoids: From Molecular Signalling to Gut–Liver Crosstalk | narrative review | 3 | 2026-04-16 | 10.3390/biology15080625 |
| Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis | research article | 4 | 2026-04-21 | 10.3390/metabo16040284 |

## What The Sources Report

- Although existing therapies, including corticosteroids, antivirals, and immunosuppressants, can delay progression of disease, they are often associated with high costs, side effects, and decreased long-term efficacy. [Dogra Shivani (2026); evidence level 3]
- Flavonoids comprise a structurally diverse group of naturally occurring polyphenolic compounds abundantly found in grains, tea, fruits, vegetables, and numerous medicinal plants. [Dogra Shivani (2026); evidence level 3]
- Accumulation of fat (triglycerides) inside the major cells of the liver (hepatocytes) and insulin resistance lead to NAFLD (also known as metabolic dysfunction-associated steatotic liver disease [MASLD]), which represents the metabolic syndrome of the liver. [Alqahtani Saif A. (2026); evidence level 4]
- The continuous fat buildup in the liver can progress from a simple steatosis (fatty liver) to a more complicated condition called non-alcoholic steatohepatitis (NASH) associated with inflammation, liver scarring (fibrosis and cirrhosis), and liver failure, as well as liver cancer in advanced cases. [Alqahtani Saif A. (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For quercetin inflammation meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Dogra Shivani (2026). Redox Reprogramming of the Diseased Liver by Dietary Flavonoids: From Molecular Signalling to Gut–Liver Crosstalk. DOI: 10.3390/biology15080625. PMCID: PMC13113924. PMID: 42041903. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13113924/
- Alqahtani Saif A. (2026). Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis. DOI: 10.3390/metabo16040284. PMCID: PMC13117325. PMID: 42042929. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13117325/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.